Stockreport

Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF Operating Expenses : Increased to $45.9 million for the full year 2023, up from $40.3 million in 2022. Net Loss : Reported a net loss of $41.4 million for the full ye [Read more]